CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 152 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $123,137,155 | -5.9% | 3,327,132 | +6.7% | 2.11% | +2.7% |
Q1 2024 | $130,908,081 | -9.1% | 3,119,087 | -14.1% | 2.05% | -12.6% |
Q4 2023 | $143,966,316 | +227.0% | 3,630,013 | +126.9% | 2.35% | +197.1% |
Q3 2023 | $44,032,000 | -5.8% | 1,600,000 | +16.1% | 0.79% | +0.1% |
Q2 2023 | $46,746,718 | -5.7% | 1,377,740 | 0.0% | 0.79% | -13.1% |
Q1 2023 | $49,571,085 | -24.0% | 1,377,740 | -5.8% | 0.91% | -29.3% |
Q4 2022 | $65,208,139 | +29.5% | 1,463,050 | -18.3% | 1.29% | +29.8% |
Q3 2022 | $50,367,000 | +29.2% | 1,791,800 | +23.9% | 0.99% | +18.8% |
Q2 2022 | $38,976,000 | -20.8% | 1,445,700 | 0.0% | 0.83% | +8.0% |
Q1 2022 | $49,241,000 | +2.9% | 1,445,700 | +16.7% | 0.77% | +26.1% |
Q4 2021 | $47,871,000 | -21.4% | 1,238,900 | +9.8% | 0.61% | -23.8% |
Q3 2021 | $60,901,000 | -13.6% | 1,128,000 | -46.5% | 0.80% | -15.2% |
Q2 2021 | $70,522,000 | +66.0% | 2,108,908 | +2.3% | 0.95% | +50.3% |
Q1 2021 | $42,486,000 | +32.0% | 2,062,433 | +12.3% | 0.63% | +27.5% |
Q4 2020 | $32,186,000 | +328.7% | 1,837,108 | +262.9% | 0.49% | +236.1% |
Q3 2020 | $7,507,000 | +24.6% | 506,179 | +9.2% | 0.15% | +12.2% |
Q2 2020 | $6,023,000 | – | 463,335 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 753,034 | $25,648,000 | 8.32% |
Octagon Capital Advisors LP | 761,398 | $25,933,000 | 5.61% |
ACUTA CAPITAL PARTNERS, LLC | 322,898 | $10,998,000 | 5.14% |
Tri Locum Partners LP | 383,319 | $13,056,000 | 5.10% |
VR Adviser, LLC | 865,116 | $29,466,000 | 4.77% |
TSP Capital Management Group, LLC | 269,045 | $9,164,000 | 3.10% |
Ikarian Capital, LLC | 595,500 | $20,282,000 | 2.67% |
Ikarian Capital, LLC | 537,958 | $18,323,000 | 2.41% |
Ghost Tree Capital, LLC | 300,000 | $10,218,000 | 2.22% |
Redmile Group, LLC | 2,046,269 | $69,696,000 | 2.18% |